Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Andersson

Showing results (821-830 of 945) with videos related to

Pageof 95
Sort By:
Respiratory Medicine|June 8, 2001
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CTA Ekberg-Jansson, B Andersson, B Bake, et al.
Plos Computational Biology|October 19, 2022
Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes researchBelén Casas, Liisa Vilén, Sophie Bauer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2014
Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytesGustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, et al.
Genome Research|August 25, 2000
Gene survey of the pathogenic protozoan Trypanosoma cruziB M Porcel, A N Tran, M Tammi, et al.
Scandinavian Cardiovascular Journal : SCJ|April 14, 2011
Estrogen receptors do not influence angiogenesis after myocardial infarctionAgneta Månsson Broberg, Anwar J Siddiqui, Helene Fischer, et al.
Biochemical Pharmacology|June 15, 2007
Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cellsMonica Ek, Therese Söderdahl, Barbara Küppers-Munther, et al.
Journal of Medicinal Chemistry|August 1, 1985
Novel dopamine receptor agonists and antagonists with preferential action on autoreceptorsA M Johansson, L E Arvidsson, U Hacksell, et al.
Clinical Pharmacology and Therapeutics|January 31, 2013
Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjectsM Ulvestad, I B Skottheim, G S Jakobsen, et al.
Spine|August 19, 2007
What is different about workers' compensation patients? Socioeconomic predictors of baseline disability status among patients with lumbar radiculopathySteven J Atlas, Tor D Tosteson, Brett Hanscom, et al.
Journal of Medicinal Chemistry|February 1, 1985
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonistsH Wikström, B Andersson, D Sanchez, et al.
Pageof 95

Showing results (821-830 of 945) with videos related to

Sort By:
Pageof 95
Respiratory Medicine|June 8, 2001
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CTA Ekberg-Jansson, B Andersson, B Bake, et al.
Plos Computational Biology|October 19, 2022
Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes researchBelén Casas, Liisa Vilén, Sophie Bauer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 2, 2014
Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytesGustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, et al.
Genome Research|August 25, 2000
Gene survey of the pathogenic protozoan Trypanosoma cruziB M Porcel, A N Tran, M Tammi, et al.
Scandinavian Cardiovascular Journal : SCJ|April 14, 2011
Estrogen receptors do not influence angiogenesis after myocardial infarctionAgneta Månsson Broberg, Anwar J Siddiqui, Helene Fischer, et al.
Biochemical Pharmacology|June 15, 2007
Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cellsMonica Ek, Therese Söderdahl, Barbara Küppers-Munther, et al.
Journal of Medicinal Chemistry|August 1, 1985
Novel dopamine receptor agonists and antagonists with preferential action on autoreceptorsA M Johansson, L E Arvidsson, U Hacksell, et al.
Clinical Pharmacology and Therapeutics|January 31, 2013
Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjectsM Ulvestad, I B Skottheim, G S Jakobsen, et al.
Spine|August 19, 2007
What is different about workers' compensation patients? Socioeconomic predictors of baseline disability status among patients with lumbar radiculopathySteven J Atlas, Tor D Tosteson, Brett Hanscom, et al.
Journal of Medicinal Chemistry|February 1, 1985
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonistsH Wikström, B Andersson, D Sanchez, et al.
Pageof 95